NXGL - Nexgel Inc

NXGL - Nexgel Inc

https://nexgel.com

Recent News

Powered by Alpha Vantage

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

GlobeNewswire • 1 month, 2 weeks ago • score: 0.41

LANGHORNE, Pa., Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- NEXGEL, Inc. ( "NEXGEL" or the "Company" ) ( NASDAQ: "NXGL" ) , a leading provider of medical and over-the-counter ( OTC ) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced ...

NEXGEL and STADA AG Announce Expansion of Partnership for North America

GlobeNewswire • 2 months ago • score: 0.46

LANGHORNE, Pa., July 14, 2025 ( GLOBE NEWSWIRE ) -- NEXGEL, Inc. ( "NEXGEL" or the "Company" ) ( NASDAQ: "NXGL" ) , a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its partnership with STADA Arzneimittel ...

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

GlobeNewswire • 4 months ago • score: 0.31

Management will host a conference call at 4:30 P.M. ET on the same day ...

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025

GlobeNewswire • 6 months ago • score: 0.45

LANGHORNE, Pa., March 13, 2025 ( GLOBE NEWSWIRE ) -- NEXGEL, Inc. ( "NEXGEL" or the "Company" ) ( NASDAQ: "NXGL" ) , a leading provider of medical and over-the-counter ( OTC ) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced ...

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

GlobeNewswire • 8 months, 1 week ago • score: 0.30

LANGHORNE, Pa., Jan. 02, 2025 ( GLOBE NEWSWIRE ) -- NEXGEL, Inc. ( "NEXGEL" or the "Company" ) ( NASDAQ: "NXGL" ) , a leading provider of medical and over-the-counter ( OTC ) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced ...

NEXGEL Announces $2,000,000 Registered Direct Offering

GlobeNewswire • 10 months ago • score: 0.34

LANGHORNE, Pa., Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- NEXGEL, Inc. ( "NEXGEL" or the "Company" ) ( NASDAQ: NXGL ) , a leading provider of medical and over-the-counter ( OTC ) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it ...

NEXGEL to Report Third Quarter 2024 Financial Results on November 13th

GlobeNewswire • 10 months ago • score: 0.31

Management will host a conference call at 4:30 P.M. ET on the same day ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

NEXGEL, Inc. manufactures aqueous, electron beam crosslinked, high water content hydrogels and polymeric gels. The company is headquartered in Langhorne, Pennsylvania.

52W High

$5.10

52W Low

$2.10

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.58

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

13.87

EV/EBITDA (<8 favorable)

-0.85

EV/Revenue (<3 favorable)

1.70

P/S (TTM) (<3 favorable)

1.53

P/B (<3 favorable)

3.83

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

15.54%

Institutions (25–75% balanced)

8.90%

Shares Outstanding

8,067,600

Float

6,838,300

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

11,672,000

Gross Profit (TTM)

4,675,000

EPS (TTM)

-0.40

Profit Margin (>10% good)

-0.25%

Operating Margin (TTM) (higher better)

-0.22%

ROE (TTM) (>15% strong)

-0.61%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.00

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—